Study of Sage-324 for the treatment of Essential Tremor (H-51443)
Description
Content
Phase 2, Double-Blind, Randomized, Placebo-Controlled, Dose-Response study of Sage-324 for the treatment of Essential Tremor
The purpose of this study is to determine if SAGE-324 reduces tremor in the arm, and whether SAGE-324 might have other effects on your essential tremor symptoms. SAGE-324 is an experimental drug, which means that the FDA has not approved it for the treatment of Essential tremor or any other indication.
Contact
Phone 1: 713–798–5989
IRB: H-51443
Status:
Active
Created:
